Anna Fokina, Sr. Associate at DCVC Bio Anna works as a Sr. Associate at DCVC Bio, early stage VC fund focused on agtech and computational life science. Previously she was on the investment team at Monsanto Growth Ventures (MGV) and worked at long-short equity hedge funds Moore Capital Management and SC [...]
Oliver Morton, The Economist‘s briefings editor. Oliver Morton is The Economist‘s briefings editor. Before coming to The Economist as energy and environment editor in 2009, he was the chief news and features editor of Nature, the international scientific journal. He specialises in the energy business, climate science and policy, and other [...]
John Nicols, President and Chief Executive Officer of Codexis. An industry veteran, John Nicols had more than 22 years at Albemarle Corporation, a maker of highly engineered specialty chemicals, before joining Codexis in 2012. He held positions at Albemarle as senior vice president for strategic development and catalysts, and vice president [...]
Junichi Sugahara, Director and Executive Officer of Spiber. Established in 2007, Spiber Inc. is a biotech startup based in Yamagata, Japan. Spiber’s revolutionary protein materials have garnered wide attention for their potential to serve as sustainable mainstay industrial materials, due to their low environmental impact, biodegradability, and non-reliance on traditional petroleum [...]
Michelle Adelman, CEO of Accite Holdings. Michelle Adelman is a seasoned strategist, recognized business leader and fierce social advocate. She is the founder of Accite, a boutique project development and impact investment firm focused on technology-led agriculture and food security projects in growth markets, particularly Southern Africa. Accite’s investment philosophy brings [...]
Esther Dyson, Executive Founder of Wellville Executive founder of Wellville, Esther (@edyson on Twitter) is an active angel investor, best-selling author, board member and advisor concentrating on emerging markets and technologies, new space and health. She sits on the boards of 23andMe and Wellpass (txt4baby), and is an investor in Big [...]
Ali Nouri, President of the Federation of American Scientists. Dr. Ali Nouri is the President of the Federation of American Scientists. Until recently he served as legislative director and national security advisor to U.S. Senator Al Franken (D-MN) where he oversaw the work of the Senator’s legislative team, drafted and negotiated [...]
Alexis Rovner, Co-founder and CEO of 64-x. Alexis Rovner is the co-founder and CEO of 64-x, a company developing recoded organisms that carry out functions and operate in environments that are otherwise inaccessible. As we enter a new age of synthetic biology where we can engineer biological systems in unprecedented ways, [...]
Aoife Brennan, President and CEO at Synlogic. Aoife is currently President and CEO at Synlogic Inc. (Nasdaq:SYBX), a clinical stage biotechnology company applying synthetic biology to probiotics to develop novel, living medicines. She joined Synlogic as Chief Medical Officer in September 2016, served as interim CEO from April 2018 and was [...]
Emily Leproust, CEO of Twist Bioscience. Emily Leproust is the CEO of Twist Bioscience. As an early pioneer in the high-throughput synthesis and sequencing of DNA, Dr. Leproust is disrupting the process of gene synthesis to enable the exponential growth of synthetic biology applications in multiple fields including medicine, DNA data [...]
